BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2915284)

  • 1. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
    Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
    J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
    Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
    J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
    Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
    Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
    Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease.
    Hyams JS; Treem WR; Carey DE; Wyzga N; Eddy E; Goldberg BD; Moore RE
    Gastroenterology; 1991 Apr; 100(4):971-5. PubMed ID: 2001833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
    Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
    Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children.
    Allen DB; Goldberg BD
    Pediatrics; 1992 Mar; 89(3):416-21. PubMed ID: 1741214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procollagen type I amino-terminal propeptide: pediatric reference data and relationship with procollagen type I carboxyl-terminal propeptide.
    Crofton PM; Evans N; Taylor MR; Holland CV
    Clin Chem; 2004 Nov; 50(11):2173-6. PubMed ID: 15502092
    [No Abstract]   [Full Text] [Related]  

  • 12. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III procollagen amino terminal propeptide: what does it measure in children?
    Wootton CI; Murphy R
    Br J Dermatol; 2012 Dec; 167(6):1391-2. PubMed ID: 22578183
    [No Abstract]   [Full Text] [Related]  

  • 14. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.
    Kaufman BD; Videon N; Zhang X; Harris MA; Shaddy RE; Goldmuntz E
    Cardiol Young; 2015 Feb; 25(2):228-36. PubMed ID: 24192074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
    Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen.
    Steinmann B; Superti-Furga A; Joller-Jemelka HI; Cetta G; Byers PH
    Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum procollagen type III aminoterminal peptide in primary fibromyalgia (fibrositis syndrome).
    Jensen LT; Jacobsen S; Hørsley-Petersen K
    Br J Rheumatol; 1988 Dec; 27(6):496. PubMed ID: 3203198
    [No Abstract]   [Full Text] [Related]  

  • 18. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
    Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
    Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
    Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.